RE: Roche update23 Mar 2021 23:42
It seems to me as though IXICO has just done it job, well, and identified the treatment won't work. The messenger is being unfairly blamed for the message.
It is a pity that the treatment has failed its trial but there is no failure in IXICO identifying that.
So the drop appears to be unfortunately aligned to the trial results and not to analysis. If Roche have been helped to identify this more quickly than might otherwise have been expected and have saved money as a result then hopefully the drop will be fairly temporary.